Şunu aradınız:: farmakokineetikat (Estonca - İngilizce)

farmakokineetikat ja
the pharmacokinetics and dosing

fondapariinuksi farmakokineetikat.
platelet inhibitors (acetylsalicylic acid), nsaids (piroxicam) and digoxin did not interact with the pharmacokinetics of fondaparinux.

tasakaalukontsentratsiooni farmakokineetikat. av
follow-up therapy with another anticoagulant medicinal product na

trametiniibi farmakokineetikat iseloomustati
the pharmacokinetics of trametinib were characterised in

4 cancidas’ e farmakokineetikat.
4 rifampicin or mycophenolate mofetil.

uuritud on busulfaani farmakokineetikat.
the pharmacokinetics of busulfan has been investigated.

ponatiniibi farmakokineetikat mõjutavad tegurid
intrinsic factors affecting ponatinib pharmacokinetics

farmakokineetikat lastel ei ole uuritud.
pharmacokinetics in the paediatric population have not been studied.

uuritud on busilvex’i farmakokineetikat.
the pharmacokinetics of busilvex has been investigated.

imetamine ei mõjutanud duloksetiini farmakokineetikat.
lactation did not influence duloxetine pharmacokinetics

sugu: sugu palonosetrooni farmakokineetikat ei mõjuta.
8 gender: gender does not affect the pharmacokinetics of palonosetron.

basedoksifeeni farmakokineetikat lastel ei ole uuritud.
the pharmacokinetics of bazedoxifene have not been studied in the paediatric population.

amlodipiini farmakokineetikat neerukahjustus oluliselt ei mõjuta.
the pharmacokinetics of amlodipine are not significantly influenced by renal impairment.

ravimi farmakokineetikat mõjutab selle kontsentratsioon süstelahuses.
the pharmacokinetic behavior of the medicinal product is influenced by its concentration in the solution for injection.

neerude kahjustus: neerude kahjustus ei mõjuta entakapooni farmakokineetikat.
renal impairment: renal impairment does not affect the pharmacokinetics of entacapone.